Genetic platforms: Do we do what we know? or do we know what we do?

Bernet, Laia; Pla, María Jesús; Jañez, Noelia Martinez.
Rev. senol. patol. mamar. (Ed. impr.) ; 34(2): 100-110, abr.-jun. 2021. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-230564

Documentos relacionados

  1. A plea for taking all available clinical information into account when assessing the predictive value of omics data.
  2. Robust prediction of t-year survival with data from multiple studies.
  3. Integrative factorization of bidimensionally linked matrices.
  4. Identifying mutual exclusivity across cancer genomes: computational approaches to discover genetic interaction and reveal tumor vulnerability.
  5. Deciphering breast cancer: from biology to the clinic.
  6. ScalpelSig Designs Targeted Genomic Panels from Data to Detect Activity of Mutational Signatures.
  7. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
  8. Integrative analysis of structural variations using short-reads and linked-reads yields highly specific and sensitive predictions.
  9. A closer look revisited: are we subjects or are we donors?
  10. Comparison of prognostic gene expression signatures for breast cancer.